AC-003

N/A

Report date: 2025/06/30 17:21:36
NME

Base Information

Drug NameAC-003
Drug Alias NameAC-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsGraft vs Host DiseaseIdiopathic Pulmonary FibrosisColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAccro Bioscience (Suzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAccro Bioscience (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseIdiopathic Pulmonary FibrosisColitis, Ulcerative +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A